Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus

NCT04970719 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped adequate cases were not available

Conditions

Interventions

Sponsor

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders